Silexion Therapeutics Corp. (SLXN)
0.2146
-0.02
(-8.64%)
USD |
NASDAQ |
Oct 09, 16:00
0.204
-0.01
(-4.94%)
After-Hours: 20:00
Silexion Therapeutics Price to Book Value : 5.754 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 5.754 |
| October 08, 2026 | 6.298 |
| October 07, 2026 | 6.800 |
| October 06, 2026 | 7.047 |
| October 05, 2026 | 7.132 |
| October 02, 2026 | 6.969 |
| October 01, 2026 | 7.481 |
| September 30, 2026 | 7.435 |
| September 29, 2026 | 8.538 |
| September 28, 2026 | 6.660 |
| September 25, 2026 | 6.980 |
| September 24, 2026 | 6.891 |
| September 23, 2026 | 8.454 |
| September 22, 2026 | 10.52 |
| September 21, 2026 | 14.59 |
| September 18, 2026 | 11.68 |
| September 17, 2026 | 10.19 |
| September 16, 2026 | 9.117 |
| September 15, 2026 | 9.117 |
| September 14, 2026 | 10.33 |
| September 11, 2026 | 9.580 |
| September 10, 2026 | 11.33 |
| September 09, 2026 | 9.371 |
| September 08, 2026 | 9.248 |
| September 04, 2026 | 9.433 |
| Date | Value |
|---|---|
| September 03, 2026 | 9.428 |
| September 02, 2026 | 9.417 |
| September 01, 2026 | 9.924 |
| August 31, 2026 | 9.913 |
| August 28, 2026 | 9.728 |
| August 27, 2026 | 9.658 |
| August 26, 2026 | 9.516 |
| August 25, 2026 | 9.787 |
| August 24, 2026 | 9.857 |
| August 21, 2026 | 10.57 |
| August 20, 2026 | 10.70 |
| August 19, 2026 | 11.08 |
| August 18, 2026 | 11.21 |
| August 17, 2026 | 11.32 |
| August 14, 2026 | 11.27 |
| August 13, 2026 | 12.33 |
| August 12, 2026 | 12.18 |
| August 11, 2026 | 27.75 |
| August 10, 2026 | 40.22 |
| August 07, 2026 | 50.14 |
| August 06, 2026 | 48.00 |
| August 05, 2026 | 48.26 |
| August 04, 2026 | 50.95 |
| August 03, 2026 | 52.29 |
| July 31, 2026 | 50.41 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLineRx Ltd. | 0.703 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 1.729 |
| Can-Fite BioPharma Ltd. | 1.380 |
| Eocene Ltd. | 0.2783 |
Price to Book Value Related Metrics
| Price | 0.2146 |
| Earnings Yield | -26.35K% |
| Market Cap | 0.2532M |